发明申请
- 专利标题： Aminopyrimidine compounds and methods of use
- 专利标题（中）： 氨基嘧啶化合物及其使用方法
-
申请号： US11304901申请日： 2005-12-16
-
公开(公告)号： US20070185133A1公开(公告)日： 2007-08-09
- 发明人: Adrian Smith , Paul Brennan , Frenel DeMorin , Gang Liu , Nick Paras , Daniel Retz , Elizabeth Rainbeau
- 申请人： Adrian Smith , Paul Brennan , Frenel DeMorin , Gang Liu , Nick Paras , Daniel Retz , Elizabeth Rainbeau
- 申请人地址： US CA Thousand Oaks
- 专利权人： Amgen, Inc.
- 当前专利权人： Amgen, Inc.
- 当前专利权人地址： US CA Thousand Oaks
- 主分类号： A61K31/513
- IPC分类号： A61K31/513 ; A61K31/506 ; C07D417/14
摘要：
The invention relates to aminopyrimidine compounds useful for treating diseases mediated by polo-like kinase 1 (Plk1). The invention also relates to the therapeutic use of such aminopyrimidine compounds and compositions thereof in treating disease states associated with abnormal cell growth and unwanted cell proliferation.
公开/授权文献
- US07786132B2 Aminopyrimidine compounds and methods of use 公开/授权日：2010-08-31
信息查询
IPC分类:
